NurExone Biologic Inc. (TSXV:NRX)
Canada
· Delayed Price · Currency is CAD 0.700
0.00 (0.00%)
At close: Dec 5, 2025
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 63.48 million as of December 5, 2025. Its market cap has increased by 49.34% in one year.
Market Cap
63.48M
Enterprise Value
62.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 63.48M, an increase of 89.58%. That is a compound annual growth rate of 20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 63.48M | 44.42% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.87B |
| Green Thumb Industries | 2.22B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.91B |
| Extendicare | 1.85B |
| Trulieve Cannabis | 1.48B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.01B |